Clinical outcomes and prognostic factors for cavernous hemangiomas of the spinal cord: a retrospective cohort study


Journal

Journal of neurosurgery. Spine
ISSN: 1547-5646
Titre abrégé: J Neurosurg Spine
Pays: United States
ID NLM: 101223545

Informations de publication

Date de publication:
12 04 2019
Historique:
entrez: 4 9 2019
pubmed: 4 9 2019
medline: 23 10 2019
Statut: epublish

Résumé

Intramedullary cavernous hemangioma (CH) is a rare vascular lesion that is mainly characterized by the sudden onset of hemorrhage in young, asymptomatic patients, who then experience serious neurological deterioration. Despite the severity of this condition, the therapeutic approach and timing of intervention for CH remain matters of debate. The aim of this study was to evaluate the clinical characteristics of CH patients before and after surgery and to identify prognostic indicators that affect neurological function in these patients. This single-center retrospective study included 66 patients who were treated for intramedullary CH. Among them, 57 underwent surgery and 9 patients received conservative treatment. The authors collected demographic, symptomology, imaging, neurological, and surgical data. Univariate and multivariate logistic regression analyses were performed to identify the prognostic indicators for neurological function. When comparing patients with stable and unstable gait prior to surgery, patients with unstable gait had a higher frequency of hemorrhagic episodes (52.4% vs 19.4%, p = 0.010), as assessed by the modified McCormick Scale. The lesion was significantly smaller in patients who underwent conservative treatment compared with surgery (2.5 ± 1.5 mm vs 5.9 ± 4.1 mm, respectively; p = 0.024). Overall, the patients experienced significant neurological recovery after surgery, but a worse preoperative neurological status was identified as an indicator affecting surgical outcomes by multivariate analysis (OR 10.77, 95% CI 2.88–40.36, p < 0.001). In addition, a larger lesion size was significantly associated with poor functional recovery in patients who had an unstable gait prior to surgery (8.6 ± 4.5 mm vs 3.5 ± 1.6 mm, p = 0.011). Once a hemorrhage occurs, surgical intervention should be considered to avoid recurrence of the bleeding and further neurological injury. In contrast, if the patients with larger lesion presented with worse preoperative functional status, surgical intervention could have a risk for aggravating the functional deficiencies by damaging the thinning cord parenchyma. Conservative treatment may be selected if the lesion is small, but regular neurological examination by MRI is needed for assessment of a change in lesion size and for detection of functional deterioration. AIS = ASIA Impairment Scale; ASIA = American Spinal Injury Association; CH = cavernous hemangioma; EBL = estimated blood loss; JOA = Japanese Orthopaedic Association; mMS = modified McCormick Scale.

Identifiants

pubmed: 31479221
doi: 10.3171/2019.1.SPINE18854
doi:

Types de publication

Journal Article

Langues

eng

Pagination

271-278

Informations de copyright

© AANS, except where prohibited by US copyright law.

Déclaration de conflit d'intérêts

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Auteurs

Narihito Nagoshi (N)

Departments of Orthopaedic Surgery

Osahiko Tsuji (O)

Departments of Orthopaedic Surgery

Daisuke Nakashima (D)

Departments of Orthopaedic Surgery

Ayano Takeuchi (A)

Preventive Medicine and Public Health, Keio University School of Medicine

Kaori Kameyama (K)

Division of Diagnostic Pathology, Keio University Hospital, Tokyo, Japan

Eijiro Okada (E)

Departments of Orthopaedic Surgery

Nobuyuki Fujita (N)

Departments of Orthopaedic Surgery

Mitsuru Yagi (M)

Departments of Orthopaedic Surgery

Morio Matsumoto (M)

Departments of Orthopaedic Surgery

Masaya Nakamura (M)

Departments of Orthopaedic Surgery

Kota Watanabe (K)

Departments of Orthopaedic Surgery

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH